No abstract available.
Blood Coagulation*

No abstract available.
Laser Coagulation* ; Prostatic Hyperplasia*

No abstract available.
Blood Coagulation Factors* ; Plasma*

No abstract available.
Lupus Coagulation Inhibitor*

No abstract available.
Dacarbazine* ; Disseminated Intravascular Coagulation

No abstract available.
Blood Coagulation* ; Humans* ; Saliva*

No abstract available.
Disseminated Intravascular Coagulation* ; Heparin*

A study on 13 deaths after operation for removal of the intracerebral blood clot has shown that the complex damage influenced almost cerebral structure due to severe trauma on the solve the intracranial pressure.It should combine many solutions (intensive care, CT scanner after operation) to limit the influence and development of the rest traumas.
Intracranial Pressure ; Blood Coagulation

Background: Statin and its derivate (simvastatin, autorvastatin, etc...) are used for dyslipidemia treatment and preventing thrombose. However, the mechanism of the antithrombotic action is still being studied. Objectives: (1) To study coagulation parameters in dyslipidemia. (2) To evaluate the effects of simvastatin on coagulation parameters in dyslipidemia patients. Subject and Method: A prospective study was carried out in a sample of 22 patients with primary hypercholesterolemia (type IIa), who were treated with simvastatin 20mg/d for 1 month. The lipid parameters (cholesterol, triglycerid, HDL, LDL) and coagulation parameters (PT, APTT, fibrinogen, factor II, V, VII, X, VIII, IX, XI) were compared between pre and post therapy, and to the control group (59 healthy people). Results: Most of coagulation parameter values (except factor VIII and X) of the pre treatment group were significantly change towards hypercoagulation (p<0.05%) when compared to the control group. After treatment, PT rate, APTT, APTT rate, fibrinogen, factor VII and IX were significantly changed towards coagulation when compared to pre treatment (p<0.05%). The plasma coagulation and lipid parameters of more than 50% of the hypercholesterolemia patients returned to normal values after treatment. Conclusions: Simvastatin therapy on dyslipidemia patients can reduce not only the level of serum lipid, but also coagulation, and proved its effectiveness in the prevention of thrombosis.
Simvastatin ; coagulation ; dyslipidemia

Background: Cirrhosis is a relatively common disease in Vietnam and many other countries. Cirrhosis develops slowly and affects the labour power and the ability of the patient\u2019s living. So it is necessary to detect and treat timely. Objectives: To evaluate some coagulation factors in cirrhotic patients and learn the relationship between coagulation and cirrhosis. Subjects and method: A descriptive, cross sectional study of various coagulation factors was conducted on 72 patients with cirrhosis in the Gastrointestinal Department of Thai Nguyen Central General Hospital from July 2007 to April 2008. The data was collected and analysedby medical statistic based on SPSS 10.0 software. Results: The proportion of haemostatic disorder with low platelet count was up to 50%. Chid-Pugh C group was the most decreased platelet group compared to Chid-Pugh A and Chid-Pugh B group. About coagulation disorder: prolonged APTT accounted for 12.5% and its increase corresponded with the seriousness of the disease; fibrinogen deficiency <2g/l was observed in 20.8% of the patients; the rate of prolonged prothrombin time was 54.2%; INR>l.7 was 19.4% of the patients and it increased gradually from mild to serious cirrhosis groups. DIC patients accounted for 29.2% of the subjects; among which, the rate of DIC in Chid A, Chid B, and Chid C groups were 10.5%, 25%, and 44.8%, respectively. Conclusion: The results proved that there was a close relationship between coagulation disorder and cirrhosis level.
coagulation factors ; cirrhotic patients